Considering that GPX4 is an essential gene in many cancer cell lines,6 it will be important to assess whether GPX4 ablation also affects the growth of corresponding MYCN‐low neuroblastomas (and therefore whether GPX4 inactivation would selectively impair MYCN‐high tumour growth). The gene discussed is MYCN; the disease is cancer.